|
发表于 2021-9-10 15:55
来自手机
|显示全部楼层
此文章由 viviancn 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 viviancn 所有!转贴必须注明作者、出处和本声明,并保持内容完整
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
https://mdpi-res.com/d_attachmen ... rep-13-00061-v2.pdf
Parents should still vaccinate their children, because the benefits of vaccination in this population against this highly transmissible disease exceed the risks of rare transient adverse events. Other known risks of COVID-19, including Kawasaki-like/MIS-C, are much greater [1,21–24]. However, with schools soon to reopen worldwide, and children being possible carriers of SARS-CoV-2, much clarification on this issue is needed as soon as possible [25].
Conclusions
Certain characteristics are pointing toward a “rare, but real” clinical entity of my- ocarditis/pericarditis following COVID-19 vaccination. First, the events occur within days since vaccination. Second, they tend to be more common in males and in younger people. Third, the number of adverse events is greater than the so-called “standard myocarditis incidence rate”. We feel that there should be at least a year of study and follow up from vaccination in clinical trials, the amount of data typically essential for full approval, instead of the 2 months required for emergency use authorization [26].
At the moment, three questions remain open and unanswered, namely: why is my- ocardium a side effect? Why are adolescent males affected the most? Why is the onset after the second dose of m-RNA vaccine?
|
|